GH (Guardant Corp) Rasio Nilai Pasar marang Nilai Buku

Guardant Health, Inc. (GH) generates revenue by selling high-cost blood tests to oncologists and pharma behemoths, leveraging a streamlined express delivery system for biomaterials that maintains strict temperature control. The stock price trend on GURU.Markets is -107.14, while the business is integrated into clinics via B2B contracts, and the pace of client base expansion depends on FDA decisions and Medicare terms.

Guardant Health, Inc. (GH) is generating high added value through its breakthrough developments in liquid biopsy and MRD diagnostics, which is reflected in the current price-to-book ratio. This indicator compares the business's market valuation with its actual net assets, revealing the degree of speculative overvaluation or undervaluation of the company during periods of liquidity volatility, thereby allowing for an objective assessment of the innovative model's resilience.